#$%^&*AU2020203896A120200702.pdf#####ABSTRACT The present disclosure provides compositions and methods for the prevention of HSV infection in an HSV seronegative individual. Herpes simplex virus (HSV) is associated in many infected individuals with recurrences that manifest themselves as cold sores and/or genital herpes, both of which are often painful and embarrassing. HSV is also of significant public health consequence in that infection with HSV increases the risk of a person acquiring human immunodeficiency virus (HIV) by 2-3 fold, with an 8-fold increased risk if the person is exposed to HIV soon after HSV is acquired. Therefore, in order to address the HIV epidemic, it is also necessary to address the HSV epidemic. -1NEWYORK/#443843.1
